Advanced gastric cancer achieving major pathologic regression after chemoimmunotherapy combined with hypofractionated radiotherapy: A case report

BACKGROUND: Currently, chemotherapy combined with immunotherapy is the established first-line standard treatment for advanced gastric cancer (GC). In addition, the combination of radiotherapy and immunotherapy is considered a promising treatment strategy. CASE SUMMARY: In this report, we present a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Meng-Long, Xu, Ruo-Ne, Tan, Cong, Zhang, Zhen, Wan, Jue-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302995/
https://www.ncbi.nlm.nih.gov/pubmed/37389115
http://dx.doi.org/10.4251/wjgo.v15.i6.1096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302995/
https://www.ncbi.nlm.nih.gov/pubmed/37389115
http://dx.doi.org/10.4251/wjgo.v15.i6.1096

Ejemplares similares